Neuromuscular Disorders

Papers
(The H4-Index of Neuromuscular Disorders is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
WMS General Information69
ENMC Themed Workshop announcement41
WMS General Information37
Editorial Board36
ENMC Mid-Career Mentoring Programme35
366P Social Vulnerability in Duchenne Muscular Dystrophy: The Impact on Boys and Carrier Mothers33
156P Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma in clinically silent and childhood-onset SMA individuals from Serbia31
355P A comprehensive education and training programme for healthcare professionals in care and research for Duchenne muscular dystrophy developed from DMD Care UK and the DMD Hub28
624P A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy and familial amyotrophic lateral sclerosis.27
81P Minimal clinically important differences in dysferlinopathy from the 10-year, multicenter Jain Clinical Outcome Study25
326P Acute adverse events after Zoledronic acid infusion are uncommon in patients with Duchenne muscular dystrophy previously treated with oral bisphosphonates25
95P Development of a myotropic gene therapy towards a first treatment for LGMDR723
279P Exploring myogenic tremor in an animal model of MYBPC1-associated myopathy: a comprehensive study23
WMS 2024 Full Programme22
365P Duchenne video assessment 2.0 scorecard performance: evaluation of inter-item and inter-scorecard relationships22
17O Schwann cell transduction and PMP22 target engagement in non-human primates supports translation of RNAi-based gene therapy for CMT1A21
46P Congenital myopathies and muscular dystrophies in the UK: a comprehensive next generation sequencing analysis of frequencies over an 8-year period (2016-2023)21
389P Natural history of bone health in Duchenne muscular dystrophy: A systematic review and implications for the design of a clinical trial21
10O The neonatal screening of SMA in Ukraine: the 18 months of experience20
203P Towards a better analysis of SMN2 structures and variants by complete sequencing of the SMN locus in an international cohort of 564 SMA patients20
0.14401197433472